CVS Health stock hits 52-week high after 3.65% rise

11 articles · Updated · MarketWatch · May 8

Shares closed at $90.55 on Friday, their third straight gain, with trading volume reaching 11.1 million, above the 50-day average of 7.8 million.
The move topped CVS's previous 52-week peak of $88.63 set on 6 May and outpaced rivals including Amazon, UnitedHealth and Elevance Health.
Broader markets also advanced, with the S&P 500 up 0.84% and the Dow Jones Industrial Average edging 0.02% higher in a positive session.

With regulators targeting its core business, can CVS's record-breaking stock surge be sustained?

CVS profits are soaring on new strategies. Will patients see lower drug prices as a result?

Is CVS's pivot to AI and insurance a sign its retail pharmacy model is becoming obsolete?